The present COVID-19 situation has highlighted the importance of determining the pandemic’s impact on healthcare. While several research have looked at the relationship between COVID-19 and neurological symptoms, the influence of the present pandemic on stroke outcomes has to be looked into more. Objectives: The current cross-sectional study was carried out to evaluate the short-term outcomes of stroke in Egyptian patients diagnosed with COVID-19 and to identify potential determinants of stroke outcomes in the short term. Methods: The current study was designed as a Cross section study that included All Patients 18 years or older with confirmed COVID- 19 presenting at the emergency department at Suez Canal university hospital. Results: The present study was designed as a cross-sectional study that included 75 patients over 18 years of age who confirmed COVID-19 presenting at the emergency department, Suez Canal university hospital fulfilling our inclusion criteria to be constituted. The prevalence of neurovascular events among the studied sample was 10% (five ischemic stroke patients, two hemorrhagic stroke patients, and one patient with cavernous sinus thrombosis). Conclusions: Neurovascular problems in COVID-19 are an important problem in clinical neurology. The hypercoagulability state might occur when there is hyperinflammation caused by a pathogenic virus. Increased blood cellular components and platelet might occur. A stimulation of the coagulation cascade is also observed. Additionally, an increased plasma concentration or viscosity during COVID-19 illness is described.